Chronic hepatitis B and C co-infection increased all-cause mortality in HAART-naive HIV patients in northern Thailand

Epidemiology and Infection

Volumn 141, Issue 9, 2013, Pages 1840-1848

  Tsuchiya, N ^a   Pathipvanich, P ^b   Rojanawiwat, A ^c   Wichukchinda, N ^c   Koga, I ^d   Koga, M ^e   Auwanit, W ^c   Kilgore, P E ^f   Ariyoshi, K ^a   Sawanpanyalert, P ^c  

^a NAGASAKI UNIVERSITY   (Japan)

^b LAMPANG HOSPITAL   (Thailand)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

^d TEIKYO UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f WAYNE STATE UNIVERSITY   (United States)

Author keywords

Co infection; hepatitis B; hepatitis C; mortality; resource limited settings

Indexed keywords

ANTIRETROVIRUS AGENT; HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; BLOOD CELL COUNT; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; PHYSICAL EXAMINATION; PREVALENCE; SEX DIFFERENCE; SURVIVAL RATE; THAILAND; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; COINFECTION; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; MALE; SEROEPIDEMIOLOGIC STUDIES; SURVIVAL ANALYSIS; THAILAND;

EID: 84881475328     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812002397     Document Type: Article

References (30)

1. Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses : A global overview. Clinics in Liver Disease 2010; 14: 1-21.
2. Gupta S, Singh S. Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients. World Journal of Gastroenterology 2006; 12: 6879-6883. (Pubitemid 44811414)
3. Nagu TJ, Bakari M, Matee M. Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health 2008; 8: 416.
4. Sungkanuparph SVA, et al. Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients : A tertiarycare-based study. Journal of the Medical Association of Thailand 2004; 87: 1349-1354.
5. Soriano V, et al. Care of HIV patients with chronic hepatitis B: Updated recommendations from the HIVHepatitis B Virus International Panel. AIDS 2008; 22: 1399-410.
6. Puoti M, et al. Natural history of chronic hepatitis B in co-infected patients. Journal of Hepatology 2006; 44 (1 Suppl.) : S65-70. (Pubitemid 43053877)
7. Soriano V, et al. Care of patients coinfected with HIV and hepatitis C virus : 2007 updated recommendations from the HCV-HIV International Panel. AIDS 2007; 21: 1073-1089. (Pubitemid 46763278)
8. Graham CS, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection : A meta-analysis. Clinical Infectious Diseases 2001; 33: 562-569. (Pubitemid 32709592)
9. The Data Collection on Adverse Events of Anti-HIV Drugs Study Group. Liver-related deaths in persons infected with the human immunodeficiency virus : The D:A:D Study. Archives of Internal Medicine. 2006; 166: 1632-1641.
10. Thompson MA, et al. Antiretroviral treatment of adult HIV infection : 2010 recommendations of the International AIDS Society-USA panel. Journal of the American Medical Association 2010; 304: 321-333.
11. WHO. Towards universal access-scaling up priority HIV/AIDS interventions in the health sector, progress report 2010. World Health Organization, 2010.
12. Klein MB, Laronde RG, Suissa S. The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 2003; 33: 365-372. (Pubitemid 36859063)
13. Piroth L, et al. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients ? AIDS 1998; 12: 381-388. (Pubitemid 28077534)
14. Ockenga J, et al. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. Journal of Hepatology 1997; 27: 18-24. (Pubitemid 27357049)
15. Nikolopoulos GK, et al. Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals : A cohort study and metaanalysis. Clinical Infectious Diseases 2009; 48: 1763-1771.
16. Gilson RJC, et al. Interactions between HIV and hepatitis B virus in homosexual men: Effects on the natural history of infection. AIDS 1997; 11: 597-606. (Pubitemid 27135881)
17. Staples JCT, Rimland Dudas D. Hepatitis C in HIV (human immunodeficiency virus), Atlanta V. A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): The effect of coinfection on survival. Clinical Infectious Diseases 1999; 29: 150-154.
18. Sulkowski MS, et al. Hepatitis C and progression of HIV disease. Journal of the American Medical Association 2002; 288: 199-206. (Pubitemid 34755280)
19. Greub BLG, et al. Study. Clinical progression, survival, and immune recovery during antiretrovial therapy in patients with HIV-1 and hepatitis C virus co-infection : The Swiss HIV Cohort Study. Lancet 2000; 356: 1800-1805.
20. Wichukchinda N, et al. TIM1 haplotype may control the disease progression to AIDS in a HIV-1-infected female cohort in Thailand. AIDS 2010; 24: 1625-1631.
21. Wichukchinda N, et al. Protective effects of IL4-589 T and RANTES-28 G on HIV-1 disease progression in infected Thai females. AIDS 2006; 20: 189-196.
22. Rothenberg R, et al. Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. New England Journal of Medicine 1987; 317: 1297-1302. (Pubitemid 17153010)
23. El-Serag HB, et al. Survival in hepatitis C and HIV co-infection : A cohort study of hospitalized veterans. Clinical Gastroenterology and Hepatology 2005; 3: 175-183. (Pubitemid 40220313)
24. Gomez-Gonzalo M, et al. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals : Functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter. Journal of Biological Chemistry 2001; 276: 35435-35443.
25. Avettand-Fenoel V, et al. Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection. Journal of Clinical Microbiology 2006; 44: 2250-2253. (Pubitemid 43902187)
26. Melegari M, et al. Conserved core protein sequences in hepatitis B virus infected patients without anti-HBc. Journal of Hepatology 1991; 13: 187-191.
27. Hoffman CJ, et al. Hepatitis B and long-term HIV outcomes in coinfected HAART recipients. AIDS 2009; 23: 1881-1889.
28. Weis N, et al. Impact of Hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals : A nationwide cohort study. Clinical Infectious Diseases 2006; 42: 1481-1487.
29. Rosenthal E, et al. Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalite 2005 survey, ANRS EN19). HIV Medicine 2009; 10: 282-289.
30. Mocroft A, et al. Is there evidence for an increase in the death rate from liver-related disease in patients with HIV? AIDS 2005; 19: 2117-2125. (Pubitemid 41669000)